Concepedia

Sharon L. Kelly

SL

Statistics

Publications

3

Citations

260

H-Index

3

Active since

2000

Affiliations

United States Food and Drug Administration(Current)

Sharon L. Kelly is an author at United States Food and Drug Administration specializing in chemotherapy, oncology, and medicine.

Publications per year

2000–2018

3

Publications

3

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Gwynn Ison, Lynn Howie, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2018 · 131 citations

, , +12

B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR α-chemokine

Matthew A. Sleeman, Jonathon K. Fraser, J. Greg Murison et al. · International Immunology · 2000 · 104 citations · Full text

, , +16

A Randomized Clinical Trial of a Videotape Intervention for Women With Chemotherapy-Induced Alopecia: A Gynecologic Oncology Group Study

Susan Nolte, James P. Donnelly, Sharon L. Kelly et al. · Oncology nursing forum · 2006 · 25 citations

, , +10

1–3 of 3